Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Casdin Capital, LLC
Director at GeneDx · 10% owner at Fulcrum Therapeutics. Filing since 22 Jul 2019.
CIK 0001534261
WGS
GeneDx Holdings Corp.
Director · 15 trades
FULC
Fulcrum Therapeutics, Inc.
10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
WGS
GeneDx Holdings Corp.
5 Jun 2026
Director
Bought
50,000
$2.64M
1.4%
WGS
GeneDx Holdings Corp.
4 Jun 2026
Director
Bought
150,000
$8.47M
4.3%
WGS
GeneDx Holdings Corp.
20 May 2026
Director
Bought
140,000
$6.13M
4.2%
WGS
GeneDx Holdings Corp.
19 May 2026
Director
Bought
185,000
$7.88M
5.8%
WGS
GeneDx Holdings Corp.
18 May 2026
Director
Bought
175,000
$7.45M
5.8%
WGS
GeneDx Holdings Corp.
22 Aug 2025
Director
Sold at will
500,000
$60.45M
14.3%
WGS
GeneDx Holdings Corp.
4 Jun 2024
Director
Bought
30,000
$675.48K
1.0%
WGS
GeneDx Holdings Corp.
3 Jun 2024
Director
Bought
100,000
$2.08M
3.4%
WGS
GeneDx Holdings Corp.
29 May 2024
Director
Bought
40,000
$842.60K
1.4%
WGS
GeneDx Holdings Corp.
28 May 2024
Director
Bought
18,304
$377.17K
0.6%
WGS
GeneDx Holdings Corp.
24 May 2024
Director
Bought
144,196
$2.90M
5.2%
WGS
GeneDx Holdings Corp.
23 May 2024
Director
Bought
7,500
$146.92K
0.3%
WGS
GeneDx Holdings Corp.
13 May 2024
Director
Bought
50,000
$1.17M
1.8%
WGS
GeneDx Holdings Corp.
5 Mar 2024
Director
Bought
900
$7.94K
0.0%
WGS
GeneDx Holdings Corp.
4 Mar 2024
Director
Bought
40,000
$349.71K
1.5%
FULC
Fulcrum Therapeutics, Inc.
22 Jul 2019
10% owner
Bought
140,000
$2.22M
30.2%
16 decisions on file.
